These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31887404)

  • 1. Medical Cannabis Authorization in Patients With Cancer in the Prelegalization Era: A Population-Based Study.
    Karim S; Cheung WY; Bu J; Jess E; Kerba M
    J Pain Symptom Manage; 2020 Jun; 59(6):1223-1231. PubMed ID: 31887404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine use in medical cannabis authorization adult patients from 2013 to 2021: Alberta, Canada.
    Dubois C; Fernandes H; Lin M; Martins KJB; Dyck JRB; Klarenbach SW; Richer L; Jess E; Hanlon JG; Hyshka E; Eurich DT
    BMC Public Health; 2024 Mar; 24(1):859. PubMed ID: 38504198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada.
    Lee C; Round JM; Klarenbach S; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Harm Reduct J; 2021 Jun; 18(1):61. PubMed ID: 34103058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada.
    Lee C; Lin M; Martins KJB; Dyck JRB; Klarenbach S; Richer L; Jess E; Hanlon JG; Hyshka E; Eurich DT
    BMC Public Health; 2021 May; 21(1):843. PubMed ID: 33933061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canadians' use of cannabis for therapeutic purposes since legalization of recreational cannabis: a cross-sectional analysis by medical authorization status.
    Balneaves LG; Brown A; Green M; Prosk E; Rapin L; Monahan-Ellison M; McMillan E; Zaid J; Dworkind M; Watling CZ
    BMC Med; 2024 Apr; 22(1):150. PubMed ID: 38589855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis.
    Round JM; Lee C; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    BMC Public Health; 2020 Jun; 20(1):987. PubMed ID: 32576158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in medical cannabis use in Ontario, Canada (2014 to 2019): Trajectory of trends, medical authorization patterns and association with recreational cannabis legalization.
    Imtiaz S; Nigatu YT; Ali F; Elton-Marshall T; Rehm J; Rueda S; Hamilton HA
    Prev Med Rep; 2024 Aug; 44():102805. PubMed ID: 39035360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.
    Lee C; Round JM; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Can J Psychiatry; 2022 Jun; 67(6):470-480. PubMed ID: 34520280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014-2017 in Ontario, Canada.
    Lee C; Voaklander D; Minhas-Sandhu JK; Hanlon JG; Hyshka E; Dyck JRB; Eurich DT
    Inj Epidemiol; 2021 Apr; 8(1):33. PubMed ID: 33906699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study.
    Zongo A; Lee C; Dyck JRB; El-Mourad J; Hyshka E; Hanlon JG; Eurich DT
    Subst Use Misuse; 2022; 57(10):1633-1641. PubMed ID: 35866679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care provider preferences for, and barriers to, cannabis use in cancer care.
    McLennan A; Kerba M; Subnis U; Campbell T; Carlson LE
    Curr Oncol; 2020 Apr; 27(2):e199-e205. PubMed ID: 32489269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers in accessing medical cannabis for children with drug-resistant epilepsy in Canada: A qualitative study.
    Elliott J; DeJean D; Potter BK; Coyle D; Clifford T; McCoy B; Wells GA
    Epilepsy Behav; 2020 Oct; 111():107120. PubMed ID: 32570201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinician views on and ethics priorities for authorizing medical cannabis in the care of children and youth in Canada: a qualitative study.
    Gunning M; Rotenberg AD; Kelly LE; Crooks B; Oberoi S; Rapoport AL; Rassekh SR; Illes J
    CMAJ Open; 2022; 10(1):E196-E202. PubMed ID: 35292477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes.
    Cortellini A; Porzio G; Cofini V; Necozione S; Giusti R; Marchetti P; Aloe Spiriti MA; Costanzi A; Peris F; Ravoni G; Spinelli G; Ficorella C; Verna L
    J Oncol Pharm Pract; 2019 Sep; 25(6):1439-1444. PubMed ID: 31042135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015.
    Rotermann M; Pagé MM
    Health Rep; 2018 Jul; 29(7):3-13. PubMed ID: 30020531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
    Hildebrand A; Minnier J; Cameron MH
    Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis use in cancer: a survey of the current state at BC Cancer before recreational legalization in Canada.
    Hawley P; Gobbo M
    Curr Oncol; 2019 Aug; 26(4):e425-e432. PubMed ID: 31548810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors.
    Calcaterra SL; Burnett-Hartman AN; Powers JD; Corley DA; McMullen CM; Pawloski PA; Feigelson HS
    BMC Cancer; 2020 May; 20(1):373. PubMed ID: 32362277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use for menopause in women aged 35 and over: a cross-sectional survey on usage patterns and perceptions in Alberta, Canada.
    Babyn K; Ross S; Makowsky M; Kiang T; Yuksel N
    BMJ Open; 2023 Jun; 13(6):e069197. PubMed ID: 37344107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of depressive disorders associated with medical cannabis authorization: A propensity score matched cohort study.
    Yana JL; Lee C; Eurich DT; Dyck JRB; Hanlon JG; Zongo A
    Psychiatry Res; 2023 Feb; 320():115047. PubMed ID: 36638694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.